C

Cocrystal Pharma
D

COCP

1.39000
USD
-0.08
(-5.44%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-1
Market Cap
14,141,568
Related Instruments
A
ABEO
-0.44500
(-8.98%)
4.51000 USD
A
AEMD
-0.02430
(-7.04%)
0.32070 USD
A
ALT
-0.23000
(-5.13%)
4.25000 USD
A
AMRX
-0.40500
(-5.19%)
7.39500 USD
A
APVO
-0.60000
(-29.70%)
1.42000 USD
A
AXSM
-8.625
(-7.99%)
99.315 USD
B
BNGO
-0.27000
(-8.11%)
3.06000 USD
C
CAPR
-0.21000
(-2.27%)
9.06000 USD
C
CLSD
-0.03020
(-3.33%)
0.87600 USD
C
COLL
-0.870
(-3.00%)
28.130 USD
C
CPRX
-1.070
(-4.44%)
23.050 USD
C
CRVS
-0.15500
(-5.18%)
2.84000 USD
C
CTRM
-0.09000
(-4.02%)
2.15000 USD
C
CTXR
-0.01500
(-1.46%)
1.01000 USD
C
CYCC
-0.02420
(-10.25%)
0.21200 USD
C
CYTH
0
(0.00%)
0 USD
D
DARE
-0.06000
(-2.03%)
2.90000 USD
D
DMAC
-0.23000
(-6.27%)
3.44000 USD
D
DRRX
-0.02510
(-3.06%)
0.79490 USD
E
EBS
-0.30200
(-6.26%)
4.52300 USD
E
ECOR
-0.26000
(-4.44%)
5.60000 USD
E
ENLV
0.01000
(1.03%)
0.98000 USD
E
ENZ
-0.03970
(-12.70%)
0.27300 USD
E
EQ
0.00650
(1.39%)
0.47400 USD
EQT
EQT
-6.050
(-11.61%)
46.060 USD
E
EVOK
-0.07000
(-2.99%)
2.27000 USD
E
EYEN
-0.15000
(-13.39%)
0.97000 USD
F
FATE
0.00800
(1.16%)
0.69810 USD
F
FNKO
-0.44000
(-7.87%)
5.15000 USD
G
GALT
0.04000
(3.13%)
1.32000 USD
I
IFRX
-0.07000
(-6.60%)
0.99000 USD
I
IMMP
-0.10000
(-6.06%)
1.55000 USD
I
INO
-0.05000
(-3.14%)
1.54000 USD
I
IONS
-1.335
(-4.68%)
27.170 USD
I
IRWD
-0.03500
(-2.56%)
1.33000 USD
J
JAGX
-0.33000
(-7.10%)
4.32000 USD
K
KALA
-0.71000
(-15.67%)
3.82000 USD
L
LADR
-0.635
(-5.67%)
10.560 USD
L
LCTX
0.01150
(2.76%)
0.42880 USD
L
LGND
-3.800
(-3.69%)
99.220 USD
L
LPTX
-0.03500
(-11.38%)
0.27260 USD
L
LTRX
-0.18000
(-8.37%)
1.97000 USD
L
LXRX
0.00570
(1.28%)
0.45010 USD
M
MARA
-0.275
(-2.45%)
10.950 USD
M
MDGL
-13.21
(-4.03%)
314.41 USD
M
MRUS
-5.130
(-12.28%)
36.660 USD
M
MTNB
0.02200
(4.27%)
0.53700 USD
N
NERV
-0.24000
(-14.63%)
1.40000 USD
N
NEXA
-0.02000
(-0.32%)
6.18000 USD
N
NINE
-0.07000
(-6.80%)
0.96000 USD
N
NKTR
-0.05220
(-8.64%)
0.55210 USD
NVS
NVS
-5.940
(-5.29%)
105.850 USD
O
OGEN
-0.01770
(-8.63%)
0.18730 USD
O
OMER
-0.21000
(-2.86%)
7.14000 USD
O
ONCY
-0.00700
(-1.38%)
0.49950 USD
O
OVID
-0.02660
(-8.78%)
0.27630 USD
P
PAVM
-0.08110
(-12.01%)
0.59440 USD
P
PDSB
-0.08630
(-8.22%)
0.96370 USD
P
PENN
-1.580
(-10.24%)
13.855 USD
P
PLX
-0.23500
(-9.04%)
2.36500 USD
P
PTN
-0.01600
(-2.99%)
0.51970 USD
R
RCKT
-0.39000
(-7.02%)
5.16500 USD
R
RCMT
-0.650
(-4.02%)
15.500 USD
R
RIGL
-0.720
(-4.07%)
16.990 USD
R
RMTI
-0.02000
(-1.96%)
1.00000 USD
S
SAGE
-0.49500
(-6.71%)
6.88000 USD
S
SCYX
-0.07070
(-7.75%)
0.84100 USD
S
SIGA
0.13000
(2.49%)
5.35000 USD
S
STOK
-0.56300
(-8.92%)
5.75000 USD
T
TGTX
-2.330
(-5.92%)
37.020 USD
T
TNXP
-1.940
(-11.09%)
15.560 USD
T
TXMD
-0.05000
(-5.32%)
0.89000 USD
U
UBX
-0.08760
(-8.85%)
0.90250 USD
V
VCEL
-1.680
(-3.86%)
41.790 USD
V
VCYT
0.440
(1.55%)
28.910 USD
V
VIR
-0.38000
(-6.38%)
5.58000 USD
V
VKTX
-1.630
(-6.72%)
22.610 USD
V
VTGN
0.05800
(2.54%)
2.33800 USD
V
VTVT
-0.240
(-1.45%)
16.300 USD
V
VXRT
-0.04590
(-12.02%)
0.33610 USD
X
XNCR
-0.36000
(-4.04%)
8.54000 USD
More
News

Title: Cocrystal Pharma

Sector: Healthcare
Industry: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.